Form 4: Metagenomi CEO Sells Shares for Tax Obligations
Insider Transaction Report
Metagenomi's CEO, Jian Irish, sold 1,602 shares of common stock to cover tax withholding obligations related to vested restricted stock units.
Summary
- Jian Irish, Chief Executive Officer and Director of Metagenomi, Inc. (MGX), reported a transaction on December 5, 2025.
- A total of 1,602 shares of common stock were disposed of at a price of $1.7719 per share.
- The sale was non-volitional, executed automatically to satisfy tax withholding obligations upon the vesting of restricted stock units granted on April 1, 2024.
- Following this transaction, Jian Irish beneficially owns 563,839 shares of Metagenomi common stock directly.
Sentiment
Score: 5
Explanation: The transaction is neutral as it represents a non-volitional sale for tax purposes, not an investment decision by the CEO.
Future Outlook
The filing does not contain any forward-looking statements or guidance.
Industry Context
This transaction is a routine insider filing for tax purposes and does not reflect a strategic move or provide insight into broader industry trends for the biotechnology or genomics sector.
Stakeholder Impact
- Shareholders: Minimal direct impact as the sale was non-volitional and for tax purposes, not indicative of a change in management's confidence in the company's prospects. The number of shares sold is a small fraction of the total outstanding shares and the CEO's overall holdings.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date restricted stock units were granted to the Reporting Person. |
| 12/05/2025 | Date of the reported transaction where shares were sold. |
| 12/08/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe transaction is a routine, non-volitional sale by the CEO to cover tax obligations on vested restricted stock units. It does not reflect a discretionary investment decision or a change in the CEO's outlook on the company's future, thus it provides no new fundamental information to alter an existing investment thesis. Investors should 'hold' based on this specific filing, awaiting more substantive operational or financial news.
Keywords
Metagenomi, MGX, Jian Irish, SEC Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.